Nov 11, 2025 · 2 hr 5 min · 16 segments
Dave Ricks, the CEO of Eli Lilly, the world's most valuable pharmaceutical company, sits down with John and Patrick to discuss the complex business of drug development. Dave explains the true origin…
Dave RicksGuest
John CollisonHostPatrick CollisonHost
Paul Janssen, as I understand it, was behind the discovery, invention, what have you, of more medications than any other single.
When some outsider comes to the clinical trial process and system and just the development pipeline overall, maybe they naively think, wow, this seems so torturous, so expensive, so bureaucratic, what have you.
If they think it can't be otherwise, you might think that they're naive, right? There's a video interview with Janssen from, I think it's from the 90s.
Paul Janssen, as I understand it, was behind the discovery, invention, what have you, of more medications than any other single.
When some outsider comes to the clinical trial process and system and just the development pipeline overall, maybe they naively think, wow, this seems so torturous, so expensive, so bureaucratic, what have you.
If they think it can't be otherwise, you might think that they're naive, right? There's a video interview with Janssen from, I think it's from the 90s.
The rest of this transcript — segmented and speaker-labeled, so you land on the exact moment something was said
Search every transcript — by keyword, by phrase, or by meaning, across every show Radar indexes
Trends — what is surging across podcasts, measured against its own baseline
Alerts — when a name you follow appears in a newly indexed episode
No account is needed to search Radar.
